Cell Biochemistry and Biophysics

, Volume 69, Issue 3, pp 421–431 | Cite as

A Long-Term Follow-Up and Comprehensive Observation of Risk and Prognosis Factors of Recurrence and Survival After Resection of Hepatocellular Carcinoma

  • Lei Hu
  • Feng Xue
  • Yunyun Li
  • Minhua Shao
  • Yanfu Sun
  • Gongtian Wei
Original Paper


Although HBV, liver function and tumor characteristics were proven as hepatocellular carcinoma (HCC) prognosis-related, no large-scale and long-term follow-up studies have ever given robust evidence about prognosis predictive effect and contribution to different stage of postoperation. In this study, we evaluated the influence of above index on overall survival (OS) and disease-free survival (DFS) and other clinical data in a rather large population and long-term follow-up. Our study consisted of 1,326 HCC patients who underwent radical resection from 1996 to 2010. Epidemiology, clinical and prognosis data were analyzed. Risk factors of OS and DFS were explored. Cumulative survival comparison between groups was performed with log-rank. Multivariate analysis for independent prognostic factors was determined by Cox proportional hazards model. HBsAg status was a universal factor of HCC recurrence, while preoperational albumin (ALB) and portal vein tumor thrombus (PVTT) affected survival during the whole lifetime. Early stage recurrence was associated with capsule intact [OR (95 %) = 1.54,1.12–2.12, p = 0.009], preoperational alpha-fetoprotein (AFP), TNM and BCLC stages were the most important prognosis factors of recurrence in the early 5 years and PVTT affected the rest time. Survival was mainly associated with tumor characteristic and ALB. Short-time survival was affected with age and AFP, while BCLC was related with the long-time survival. We confirmed that during different periods after resection, factors affecting prognosis did not remain unchanged. Liver function and tumor characteristic affected DFS and OS the whole time, especially the early recurrence. However, HBV infection situation was associated with later recurrence. PVTT showed an opposite effect between early and later recurrence.


Hepatocellular carcinoma Prognosis Overall survival Disease-free survival 


  1. 1.
    Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001). Estimating the world cancer burden: GLOBOCAN 2000. International Journal of Cancer, 94(2), 153–156.CrossRefGoogle Scholar
  2. 2.
    Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55(2), 74–108.Google Scholar
  3. 3.
    Sherman, M. (2005). Hepatocellular carcinoma: epidemiology, risk factors, and screening [Review]. Seminars in Liver Disease, 25(2), 143–154.PubMedCrossRefGoogle Scholar
  4. 4.
    Yamamoto, J., Okada, S., Shimada, K., Okusaka, T., Yamasaki, S., Ueno, H., et al. (2001). Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology, 34(4 Pt 1), 707–713.PubMedCrossRefGoogle Scholar
  5. 5.
    Chen, M. S., Li, J. Q., Zheng, Y., Guo, R. P., Liang, H. H., Zhang, Y. Q., et al. (2006). A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Annals of Surgery, 243(3), 321–328.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Jianyong, L., Xuejun, K., Yinnong, Z., Zhiming, Z., Weiping, Y., Qingguo, M., et al.. (2009). Analysis of risk factors influencing intrahepatic recurrence of hepatocellular carcinoma after curative resection. Chinese Journal of Operative Procedures of General Surgery, 3(4), 008–010.Google Scholar
  7. 7.
    Nanashima, A., Abo, T., Hamasaki, K., Wakata, K., Tominaga, T., Hidaka, S., et al. (2011). Perioperative non-tumorous factors associated with survival in HCC patients who underwent hepatectomy. Anticancer Research, 31(12), 4545–4551.PubMedGoogle Scholar
  8. 8.
    Yang, T., Zhang, J., Lu, J. H., Yang, G. S., Wu, M. C., & Yu, W. F. (2011). Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World Journal of Surgery, 35(9), 2073–2082.PubMedCrossRefGoogle Scholar
  9. 9.
    Kumar, M., Kumar, R., Hissar, S. S., Saraswat, M. K., Sharma, B. C., Sakhuja, P., et al. (2007). Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case-control study of 213 hepatocellular carcinoma patients from India. Journal of Gastroenterology and Hepatology, 22(7), 1104–1111.PubMedCrossRefGoogle Scholar
  10. 10.
    Schlaeger, C., Longerich, T., Schiller, C., Bewerunge, P., Mehrabi, A., Toedt, G., et al. (2008). Etiology-dependent molecular mechanisms in human hepatocarcinogenesis [Research Support, Non-US Gov’t]. Hepatology, 47(2), 511–520.PubMedCrossRefGoogle Scholar
  11. 11.
    Schwalbe, M., Ohlenschlager, O., Marchanka, A., Ramachandran, R., Hafner, S., Heise, T., et al. (2008). Solution structure of stem-loop alpha of the hepatitis B virus post-transcriptional regulatory element. Nucleic Acids Research, 36(5), 1681–1689.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Memon, K., Kulik, L., Lewandowski, R. J., Wang, E., Ryu, R. K., Riaz, A., et al. (2012). Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis [Research Support, N.I.H., Extramural]. Journal of Hepatology, 56(5), 1112–1120.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Yang, H. I., Lu, S. N., Liaw, Y. F., You, S. L., Sun, C. A., Wang, L. Y., et al. (2002). Hepatitis B e antigen and the risk of hepatocellular carcinoma [Research Support, Non-US Gov’t]. The New England Journal of Medicine, 347(3), 168–174.PubMedCrossRefGoogle Scholar
  14. 14.
    Kubo, S., Hirohashi, K., Tanaka, H., Tsukamoto, T., Shuto, T., Yamamoto, T., et al. (2000). Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma [Research Support, Non-US Gov’t]. Cancer, 88(5), 1016–1024.PubMedCrossRefGoogle Scholar
  15. 15.
    Kubo, S., Hirohashi, K., Yamazaki, O., Matsuyama, M., Tanaka, H., Horii, K., et al. (2002). Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B [Research Support, Non-US Gov’t]. World Journal of Surgery, 26(5), 555–560.PubMedCrossRefGoogle Scholar
  16. 16.
    Yang, P., Li, Q. J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., et al. (2012). TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell, 22(3), 291–303.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Kaibori, M., Tanigawa, N., Matsui, Y., Kwon, A. H., Sawada, S., & Kamiyama, Y. (2004). Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma [Clinical Trial Randomized Controlled Trial]. Anticancer Research, 24(3b), 1929–1933.PubMedGoogle Scholar
  18. 18.
    Ohata, K., Hamasaki, K., Toriyama, K., Ishikawa, H., Nakao, K., & Eguchi, K. (2004). High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Journal of Gastroenterology and Hepatology, 19(6), 670–675.PubMedCrossRefGoogle Scholar
  19. 19.
    Hanazaki, K., Kajikawa, S., Shimozawa, N., Mihara, M., Shimada, K., Hiraguri, M., et al. (2000). Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. Journal of the American College of Surgeons, 191(4), 381–388.PubMedCrossRefGoogle Scholar
  20. 20.
    Capussotti, L., Muratore, A., Amisano, M., Polastri, R., Bouzari, H., & Massucco, P. (2005). Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival—A European single center experience. European Journal of Surgical Oncology, 31(9), 986–993.PubMedCrossRefGoogle Scholar
  21. 21.
    Hanazaki, K., Matsushita, A., Nakagawa, K., Misawa, R., & Amano, J. (2005). Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma. Hepato-Gastroenterology, 52(62), 552–557.PubMedGoogle Scholar
  22. 22.
    Peng, S. Y., Chen, W. J., Lai, P. L., Jeng, Y. M., Sheu, J. C., & Hsu, H. C. (2004). High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and beta-catenin mutations [Research Support, Non-US Gov’t]. International Journal of Cancer Journal International du Cancer, 112(1), 44–50.PubMedCrossRefGoogle Scholar
  23. 23.
    Tung-Ping Poon, R., Fan, S. T., & Wong, J. (2000). Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma [Review]. Annals of Surgery, 232(1), 10–24.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Leone, N., & Rizzetto, M. (2005). Screening for hepatocellular carcinoma] [Review. Minerva Medica, 96(2), 95–108. ita.PubMedGoogle Scholar
  25. 25.
    Ren, F. Y., Piao, X. X., & Jin, A. L. (2006). Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma [Evaluation Studies]. World Journal of Gastroenterology, 12(29), 4656–4659.PubMedGoogle Scholar
  26. 26.
    Soresi, M., Magliarisi, C., Campagna, P., Leto, G., Bonfissuto, G., Riili, A., et al. (2003). Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma [Research Support, Non-US Gov’t]. Anticancer Research, 23(2C), 1747–1753.PubMedGoogle Scholar
  27. 27.
    Tateishi, R., Yoshida, H., Matsuyama, Y., Mine, N., Kondo, Y., & Omata, M. (2008). Diagnostic accuracy of tumor markers for hepatocellular carcinoma: A systematic review. Hepatology International, 2(1), 17–30.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Weiju, S. (2007). Alpha-fetoprotein changing and tumor recurrence after liver transplantation for patients with hepatocellular carcinoma. Hangzhou: Zhejiang University.Google Scholar
  29. 29.
    Hui-chuan, S., Wei, Z., Lun-xiu, Q., Qing-hai, Y., Lu, W., Ning, R., et al. (2007). Effect of preoperative serum HBeAg status on recurrence and survival in hepatocellular carcinoma patients after radical Resection. Chinese Journal of Bases and Clinics in General Surgery, 14, 32–37.Google Scholar
  30. 30.
    Poon, R. T., Fan, S. T., Ng, I. O., Lo, C. M., Liu, C. L., & Wong, J. (2000). Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer, 89(3), 500–507.PubMedCrossRefGoogle Scholar
  31. 31.
    Ochiai, T., Ikoma, H., Okamoto, K., Kokuba, Y., Sonoyama, T., & Otsuji, E. (2012). Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection. World Journal of Surgery, 36(1), 136–143.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.The Second Department of Liver SurgeryEastern Hepatobiliary Hospital Affiliated to the Second Military Medicine CollegeShanghaiChina
  2. 2.The Fourth Department of Liver SurgeryEastern Hepatobiliary Hospital Affiliated to the Second Military Medicine CollegeShanghaiChina
  3. 3.Department of Pulmonary Medicine, Shanghai Chest HospitalAffiliated to Jiaotong UniversityShanghaiChina

Personalised recommendations